TPI
TrumpEconomyImmigrationCrimeCongressHealthcareCourts
Subscribe
TPI
The Political Insider
thepoliticalinsider.com|Privacy Policy|Contact|© 2026 The Publisher Desk

Psychedelic Stocks Surge on Trump FDA Order

April 20, 2026·about 4 hours ago·via U.S. News & World Report
Psychedelic Stocks Surge on Trump FDA Order
Trump orders FDA to fast-track psychedelic drug reviews, sparking a rally in makers like those pushing psilocybin for mental health. Cutting red tape frees innovation from big government strangleholds, boosting individual liberty over nanny-state bans. Critics cry risks, but evidence shows promise for veterans' PTSD without opioid traps. America First prioritizes American breakthroughs, not endless bureaucracy. This deregulatory win delivers real results. Read more about this...

Related Coverage

WebsiteIran's Last Chance To Avoid Finding Out What's Behind Door Number B-2 — Hot Air
WebsiteSara Gonzales exposes Maine school for inviting sexually charged queer dancer to perform for middle and high school kids — The Blaze
SubstackBill Kristol & Ryan Goodman: How Trump Could Weaponize Surveillance — The Bulwark
WebsiteWorried about airport collisions? Gamers are coming to the rescue — The Blaze
WebsiteEliminating Fraud At The Forefront of President’s Agenda — The Gateway Pundit
WebsiteFTC orders pest-control company to cease employees' noncompete agreements — Washington Times